Drugs / HER-2/neu peptide vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00791037 | Oct 2008 → Jul 2013 | HER2 positive breast carcinoma, male breast carcinoma | University of Washington | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HER-2/neu peptide vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00791037 ↗ |
| Modality | Vaccine | “HER2/neu peptide vaccine” NCT00791037 ↗ |
| Route | Other | “intradermally (ID)” NCT00791037 ↗ |